Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yoshiko Masaoka
Intravenous Administration of Adenosine Triphosphate Disodium During Primary Percutaneous Coronary Intervention Attenuates the Transient Rapid Improvement of Myocardial Wall Motion, Not Myocardial Stunning, Shortly After Recanalization in Acute Anterior Myocardial Infarction
Journal of Cardiology
Cardiovascular Medicine
Cardiology
Related publications
Percutaneous Coronary Intervention in Stable Patients After Acute Myocardial Infarction
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Predictors of Mortality After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
Angiology
Cardiovascular Medicine
Cardiology
Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction in Nonagenarians
Heart
Cardiovascular Medicine
Cardiology
Heart Rate Turbulence in Patients After Primary Percutaneous Coronary Intervention and Fibrinolytic Treatment for Acute Myocardial Infarction
Medical Journal of Indonesia
Medicine
Acute Inferior Wall ST Segment Elevation Myocardial Infarction Caused Atrial Lead Dysfunction Reversed by Primary Percutaneous Coronary Intervention
International Heart Journal
Medicine
Cardiovascular Medicine
Cardiology
Periprocedural Temporary Pacing in Primary Percutaneous Coronary Intervention for Patients With Acute Inferior Myocardial Infarction
Clinical Interventions in Aging
Medicine
Gerontology
Geriatrics
Non Surgical Coronary Artery Recanalization in Acute Transmural Myocardial Infarction
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Persistent Oxidative Stress After Myocardial Infarction Treated by Percutaneous Coronary Intervention
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Effects of No-Reflow Phenomenon on Ventricular Systolic Synchrony in Patients With Acute Anterior Myocardial Infarction After Percutaneous Coronary Intervention
Therapeutics and Clinical Risk Management
